RESEACH HIGHLIGHTS

Type I IFNs and CD8 T cells increase intestinal barrier permeability after chronic viral i...

PRODUCT HIGHLIGHTS

InVivoMAb anti-human CD220 / Insulin Receptor (Clone IR 83-22)The IR 83-22 monoclonal anti...

PRODUCT HIGHLIGHTS

Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with ...

2020년 대한면역학회 국제학술대회(KAI Internati...

2020년 대한면역학회 국제학술대회(KAI International Meeting 2020)​바이오엑스셀코리아(BioXCell Kor...

[August 13th-14th, 2020] the Korean Society f...

 Bio X Cell Korea had the opportunity to exhibit at the Korean Society for Stem Cell ...

춘계학술대회 취소 안내 BioXCell Eco Bag 증정 EVENT -춘계 학술대회를 위해 준비...

4월 신제품 할인 [#BE0332]

Featured Product ...

Bio X Cell is now offering a discount to inve...

 Bio X Cell is now offering a discount to investigators who are setting up a new lab....

☆★전품목 3월 할인이벤트☆★

BioXCell Korea 설립 EVENT!!*전 제품 할인 프로모션* ​행사기간 : 03월 01일 – 26일​Bio...

[#BE0341] InVivoMAb anti-human EphA2

 About InVivoMAb anti-human EphA2The B2D6 monoclonal antibody reacts with human ...

[#BE0340] InVivoMAb anti-human/monkey MDR-1 (...

About InVivoMAb anti-human/monkey MDR-1 (CD243)The UIC2 monoclonal antibody reacts wi...

[#BE0339] InVivoMAb anti-mouse NKG2AB6

About InVivoMAb anti-mouse NKG2AB6The 16A11 monoclonal antibody reacts with NKG2A fro...